$24亿医药和解

12 月 1, 2017

该公司是协助解决约 10,000 名声称因药物受伤的 Actos ®用户的索赔的诉讼团队的一部分。设计和处方用于帮助 2 型糖尿病患者控制血糖,使用 Actos 的患者被诊断出膀胱癌的几率很高。在多次做出有利于多位原告的判决后,武田制药及其关联企业被迫与 10,000 名这种糖尿病药物的使用者达成和解,其中一些人是 Napoli Shkolnik 法律团体的代表。因此,武田同意以 $24 亿美元的和解来解决这些案件

类别: 医药诉讼

PFAS in Biosolids: 2025 Statehouses Take the Lead

For PFAS in biosolids, 2025 was the year statehouses stepped decisively into the vacuum. While federal policy is evolving, state and local governments are rapidly redrawing the rules...

阅读文章
Suspected Birth Injury? What Parents Need to Know and Do Next

Bringing a baby into the world is supposed to be joyful. When something goes wrong during pregnancy, labor, or delivery, that joy can be replaced in an instant...

阅读文章
A Traveler’s Guide to Responding to a Car Accident

The holiday season is meant for connection and celebration, but travel can add unexpected pressure. Beginning at the end of November, more drivers take to the roads, increasing...

阅读文章
联系我们:
获得免费案例评估 律师推荐

我们的位置

联系我们 亲自预约